Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Leopoldo Pérez de Isla, Kausik K. Ray, Gerald F. Watts, Raul D. Santos, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, Jose Luis Diaz-Diaz, Lina Badimon, Alberico L. Catapano, Pedro Mata

Research output: Contribution to journalArticle

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia'. Together they form a unique fingerprint.

Medicine & Life Sciences